Nutrition Business Journal

An ingredient story

Michael Jeffers is a supplement industry veteran and president and CEO of Helios Corp. We talked to him about the challenges of introducing a product in the menopause space, where confusion, a history of health risks and anxiety complicate the market.

nbj: Consumers are confused about hormone replacement, with some of the biggest perceptions involving cancer risks, what are the challenges in presenting a natural alternative for menopausal conditions?

Jeffers: In 2002, the Women’s Health Initiative (WHI) as sponsored by the National Institutes of Health evaluated 15,000 women to once and for all determine if hormone replacement therapy (HRT) was linked to cancer. The study never mad

All access premium subscription

This content requires a subscription to Nutrition Business Journal.

As an NBJ subscriber, you receive 10 issues a year and access to the exclusive “NBJ subscriber only” content on (excludes three-month subscriptions), which includes PowerPoint presentations, select data charts and archived articles. Subscribers also receive a 10 percent discount on data charts, comprehensive market research reports and webinars.

Email [email protected] for more information about subscribing.

Hide comments


  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.